pone.0254305.g006.tif (174.58 kB)
Cell viability analysis.
figure
posted on 2021-09-30, 17:30 authored by Nikita Lomis, Susan Westfall, Dominique Shum-Tim, Satya PrakashCell viability analysis on H9c2 cells treated with MRN-Lactate, AT1-HSA-MRN-NPs and AT1-HSA-NPs at 1 mM MRN concentration at (a) 4 hours, (b) 24 hours and (c) 48 hours. The graph shows a representative result of mean ± SD (n = 3). ****p<0.0001 was considered highly significant and ***p<0.001, **p<0.01 and *p<0.05 were considered significant based on Tukey’s posthoc analysis.
History
Usage metrics
Categories
Keywords
lacking target specificityexhibits low bioavailabilityexhibit superior targetingcovalent conjugation reaction9 ± 18 ± 2improves myocardial contractility4 ± 14 %, respectively2 ± 4overexpressing at1 receptorsh9c2 cells treateddrug delivery characteristicsdiv >< pcongestive heart failuretargeted cardiac uptakeheart failureh9c2 cellstargeted drugtargeted deliverymyocardial infarctioncardiac functionzeta potentialvs 44vivo vasodilatory effectssurface functionalizedsignificantly highernanoparticle sizeintracellular uptakehypertrophic conditionscumulative releaseangiotensin ii7 nm7 mv24 hrs
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC